Top Markets
#1 MowCat MowCat +781.41%
#2 Islamic Coin Islamic Coin +152.09%
#3 龙虾 (Lobster) 龙虾 (Lobster) +85.82%
#4 Akedo Akedo +57.05%
#5 Magma Finance Magma Finance +42.91%
#6 MarsCoin MarsCoin +32.74%
#7 Pons Pons +32.28%
#8 SIXSEVEN SIXSEVEN +30.44%
#9 DeXe DeXe +27.75%
#10 Cortex Cortex +26.60%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Pozycja w akcjach #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Cena akcji
$48.45
Kapitalizacja rynkowa
$1.39B
Zmiana (1 dzień)
1.16%
Zmiana (1 rok)
-
Kraj
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Kategoria

Healthcare
Historia stopy dywidendy dla LB Pharmaceuticals Inc Common Stock (LBRX)
Stopa dywidendy (TTM) dla LB Pharmaceuticals Inc Common Stock (symbol akcji: LBRX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla LB Pharmaceuticals Inc Common Stock (LBRX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH